Clinical Trial Update: Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease [NA]

View source ↗

Summary

This update covers the clinical trial of KL003 Cell Injection for severe sickle cell disease, noting that the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• KL003 cell injection

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Sickle Cell Disease | NA | Status: NOT_YET_RECRUITING